Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Vascular anomalies
•
Vasculitis
•
General Rheumatology
•
Inherited connective tissue disease
•
Neurology
How would you approach evaluation of a patient with multiple vertebral artery pseudoaneurysms and history of dissection, but without other areas of pseudoaneurysms?
Related Questions
When do you obtain nerve biopsy to evaluate for vasculitic neuropathy in patients with distal symmetric polyneuropathies?
How do you counsel patients with postural orthostatic tachycardia syndrome (POTS) regarding safe and effective exercise regimens?
In a patient with strong serologic evidence of SLE presenting with isolated bilateral lower limb sensorimotor neuropathy, normal neuroimaging, and CSF, would you initiate cyclophosphamide with pulse-dose steroids upfront, or reserve escalation (e.g., plasma exchange or immunosuppressants) for cases refractory to steroids?
Should patients starting cyclophosphamide be screened routinely for latent tuberculosis (TB)?
What biologic or conventional/synthetic DMARD would you use as a steroid sparing agent in a patient with GCA and a history of diverticulitis?
How do you evaluate and manage brain fog in patients with underlying rheumatic disease?
What are your vaccine recommendations while patients are on biologics?
How would you approach management of a patient with mixed cryoglobulinemic vasculitis with predominant skin involvement and no major organ involvement?
How do you approach evaluation of a patient with symmetric length dependent axonal sensorimotor neuropathy and +ANA but no current signs or symptoms of rheumatologic disease?
What options are available for patients who require high dose steroids while taking strong CYP4A4 inducers?
